Prostate Cancer and Radical Treatment
The most common histological type of prostate cancer is adenocarcinoma (cancer cells arising from glandular tissue). Active curative treatment for patients diagnosed with prostate cancer, include radiotherapy (radiation directed at the prostate) or brachytherapy (insertion of radioactive seeds into the prostate gland) or radical surgery (surgical removal of the prostate gland and surrounding lymph nodes). Surgery can be conducted as an ‘open’ procedure, with cameras (laparoscopic) or using a robot (robotically). For the purposes of this book, the focus is on men post radical robotic surgery for prostate cancer.
- 2.Barnett C, Kumar P, Challacombe B, Dasgupta P. Robot assisted laparoscopic prostatectomy. Striving for Trifecta outcomes in localised prostate cancer. Minerva Med. 2011;102:333–8.Google Scholar
- 6.D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969–74.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.D’Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Tomaszewski JE, Wein A. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol. 1998;160:2096–101.CrossRefGoogle Scholar